| abstract |
(57) [Summary]nThe present invention relates to novel aromatic diketo derivatives and their pharmaceutically acceptable salts, esters, ethers and other obvious chemical equivalents. The derivative is a glucose-6-phosphate translocase inhibitor and can be used in the treatment of diabetes mellitus. The invention further relates to a process for the preparation of derivatives, the use of the derivatives and their pharmaceutically acceptable salts, esters, ethers and other obvious chemical equivalents as medicaments, in particular in the treatment of diabetes mellitus, and derivatives, It relates to a pharmaceutical composition comprising pharmaceutically acceptable salts, esters, ethers or other obvious chemical equivalents. |